These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress. Gengo FM J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S319-25. PubMed ID: 8977543 [TBL] [Abstract][Full Text] [Related]
11. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. Monroe EW; Daly AF; Shalhoub RF J Allergy Clin Immunol; 1997 Feb; 99(2):S798-806. PubMed ID: 9042073 [TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology of second-generation antihistamines. Grant JA Allergy Asthma Proc; 2000; 21(3):135-40. PubMed ID: 10892514 [TBL] [Abstract][Full Text] [Related]
13. H1-antihistamines and the central nervous system. Welch MJ; Meltzer EO; Simons FE Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223 [TBL] [Abstract][Full Text] [Related]
14. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Wiseman LR; Faulds D Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167 [TBL] [Abstract][Full Text] [Related]
16. Evolution of H1-receptor antagonist treatment. Simons FE Ann Allergy; 1993 Sep; 71(3):282-7. PubMed ID: 8103973 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
18. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Golightly LK; Greos LS Drugs; 2005; 65(3):341-84. PubMed ID: 15669879 [TBL] [Abstract][Full Text] [Related]
19. Safety considerations in the management of allergic diseases: focus on antihistamines. Yanai K; Rogala B; Chugh K; Paraskakis E; Pampura AN; Boev R Curr Med Res Opin; 2012 Apr; 28(4):623-42. PubMed ID: 22455874 [TBL] [Abstract][Full Text] [Related]
20. Rupatadine: global safety evaluation in allergic rhinitis and urticaria. González-Núñez V; Bachert C; Mullol J Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]